$27.28
Value $1.3B
EPC and PG stock compared: price, dividend, valuation and results, from SEC filings.
$27.28
Value $1.3B
$169.80
Value $395B
Edgewell Personal Care (EPC) has a market value of $1.3B and Procter & Gamble (PG) $395B. Over the last year, with dividends, EPC moved +48.4% and PG +18.0%. Dividend yield: EPC 2.20%, PG 2.55%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
EPC$1.3B
PG$395B
PG is 314 times EPC
Revenue, 12 months
EPC$2.0B
PG$87.9B
PG is 44 times EPC
Net income, 12 months
EPC-$52M
PG$16.0B
Operating margin
EPC2.1%
PG22.6%
20.5 points apart
ROIC
EPC1.2%
PG17.3%
16.1 points apart
P/E
EPC–
PG25.1
Dividend yield
EPC2.2%
PG2.6%
0.4 points apart
5-year return
EPC-30.7%
PG+31.8%
62.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
EPC-30.7%
PG+31.8%
| Period | EPCWith dividends | PGWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +48.4%Price +44.3% | +18.0%Price +14.7% |
| 3 years since November 13, 2023 | -14.7%-5.2% a yearPrice -20.1% | +20.5%+6.4% a yearPrice +11.4% |
| 5 years since November 12, 2021 | -30.7%-7.1% a yearPrice -37.0% | +31.8%+5.7% a yearPrice +15.9% |
| 10 years since November 15, 2016 | -62.6%-9.4% a yearPrice -66.6% | +166.5%+10.3% a yearPrice +103.1% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
EPCEdgewell Personal CarePGProcter & Gamble
| Price | $27.28 | $169.80 |
|---|---|---|
| Market value | $1.3B | $395B |
| Enterprise value (EV) | $2.1B | $418B |
| P/E | – | 25.1 |
| P/E, 5-year median | 19.3 | 24.8 |
| P/B | 0.9 | 7.2 |
| EV/EBIT | 51.4 | 21.1 |
| Free cash flow yield | – | 3.9% |
| Revenue, 12 months | $2.0B | $87.9B |
|---|---|---|
| Net income, 12 months | -$52M | $16.0B |
| Free cash flow, 12 months | -$10M | $15.3B |
| Earnings per share, 12 months | -$1.12 | $6.64 |
| Revenue growth, year on year | 1.8% | 3.3% |
| Revenue growth a year, past | -0.9%over 5 years | +2.7%over 5 years |
| EPS growth a year, past | – | +3.8%over 5 years |
| Gross margin | 41.6% | 49.8% |
|---|---|---|
| Operating margin | 2.1% | 22.6% |
| Net margin | -2.6% | 18.2% |
| ROIC | 1.2% | 17.3% |
| ROE | -3.5% | 29.5% |
| Cash | $376M | $15.4B |
|---|---|---|
| Total debt | $1.3B | $38.9B |
| Net debt / EBITDA | 7.3 | 1.0 |
| Interest cover | 0.6× | 22.0× |
| Dividend yield | 2.2% | 2.6% |
|---|---|---|
| Dividend per share, 12 months | $0.60 | $4.32 |
| Dividend growth a year, past | +5.4%over 5 years | +5.6%over 5 years |
| Buyback yield | 1.3% | 1.3% |
| Shareholder yield | 3.5% | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Procter & Gamble ($395B) is about 313.9 times Edgewell Personal Care ($1.3B), at today's prices.
Since November 15, 2016, EPC's price moved -66.6% and PG's +103.1%. With dividends: EPC -62.6% (-9.4% a year), PG +166.5% (+10.3% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.20% for Edgewell Personal Care and 2.55% for Procter & Gamble. Over the last twelve months they paid $0.60 and $4.32 per share.
Over the last twelve months, the net margin was -2.6% for Edgewell Personal Care and 18.2% for Procter & Gamble, and the operating margin 2.1% and 22.6%. Revenue was $2.0B and $87.9B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.